Ob Medicos, PLLC
Ob Medicos, PLLC was paid $5.22M by Medicaid between Jan 2018 and Dec 2024, across 97 billing codes. Its largest line is 99214, doctor's office visit, returning patient (more involved) — 22% of everything it billed.
33Billing provider infoOB MEDICOS, PLLC
CHATTANOOGA, TN 37408
CHATTANOOGA, TN 37408
33aNPI1548664840assigned 10/15/2014
33bProvider typeSpecialist
28Total paid$5.22M
24GClaims177,455
24DCodes billed97
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other Specialist providers in Tennessee
Rank by total paid#8 of 252
Median peer was paid$57K
This provider vs. median92×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 9,919 | $317K | |
| 2019 | 17,032 | $443K | |
| 2020 | 17,508 | $471K | |
| 2021 | 34,579 | $959K | |
| 2022 | 35,480 | $1.05M | |
| 2023 | 32,791 | $981K | |
| 2024incomplete | 30,146 | $998K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99214 | Doctor's office visit, returning patient (more involved)Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity | 22% | 18,390 | 15,527 | $1.17M |
| 99213 | Doctor's office visit, returning patient (routine)Office or other outpatient visit for the evaluation and management of an established patient, low complexity | 12% | 15,426 | 13,193 | $649K |
| 90460 | Immunization administration through 18 years of age via any route, first or only component | 12% | 13,483 | 11,795 | $617K |
| 99391 | Periodic comprehensive preventive medicine reevaluation, established patient, infant (under 1 year) | 9.6% | 7,713 | 6,816 | $501K |
| 96110 | Developmental screening, with scoring and documentation, per standardized instrument | 7.1% | 15,723 | 12,453 | $372K |
| 99392 | Periodic comprehensive preventive medicine reevaluation, established patient, early childhood (1-4 years) | 6.5% | 4,688 | 4,196 | $341K |
| 99492 | 2.6% | 1,346 | 1,065 | $134K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | 2.5% | 2,169 | 1,648 | $133K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | 2.3% | 1,679 | 1,217 | $118K |
| 99493 | 1.8% | 1,062 | 921 | $95K | |
| 59410 | 1.8% | 120 | 92 | $94K | |
| 0240U | 1.7% | 653 | 610 | $89K |
85 more codes
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.5% | 580 | $80K |
| 99393 | Periodic comprehensive preventive medicine reevaluation, established patient, late childhood (5-11 years) | 1.3% | 965 | $67K |
| 99215 | Doctor's office visit, returning patient (complex) | 1.1% | 656 | $59K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 1.1% | 1,518 | $59K |
| 99494 | 1.0% | 911 | $54K | |
| 59025 | Fetal non-stress test | <1% | 1,540 | $51K |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 2,948 | $37K |
| D1206 | Topical application of fluoride varnish | <1% | 2,379 | $33K |
| 99484 | <1% | 932 | $32K | |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | <1% | 3,612 | $28K |
| 0503F | <1% | 1,150 | $28K | |
| 90715 | <1% | 720 | $28K | |
| 99238 | Hospital discharge day management, 30 minutes or less | <1% | 501 | $26K |
| 36415 | Collection of venous blood by venipuncture | <1% | 10,244 | $23K |
| 90686 | <1% | 4,326 | $20K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 215 | $19K |
| D0190 | <1% | 2,385 | $19K | |
| 90471 | Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine | <1% | 2,452 | $19K |
| 96127 | <1% | 4,293 | $17K | |
| 99202 | Office or other outpatient visit for the evaluation and management of a new patient, straightforward | <1% | 488 | $15K |
| 99394 | Periodic comprehensive preventive medicine reevaluation, established patient, adolescent (12-17 years) | <1% | 191 | $15K |
| 99212 | Office or other outpatient visit for the evaluation and management of an established patient, straightforward | <1% | 700 | $15K |
| 81025 | <1% | 2,550 | $13K | |
| 0011A | <1% | 387 | $10K | |
| 87428 | <1% | 180 | $10K | |
| 99177 | <1% | 1,792 | $9K | |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | <1% | 223 | $8K |
| 99460 | <1% | 146 | $7K | |
| 98960 | <1% | 145 | $7K | |
| 0012A | <1% | 272 | $7K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 445 | $7K |
| 81003 | <1% | 3,221 | $6K | |
| 59430 | <1% | 426 | $6K | |
| J1050 | Injection, medroxyprogesterone acetate, 1 mg | <1% | 82 | $5K |
| 90661 | <1% | 580 | $5K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 466 | $5K |
| 90670 | <1% | 3,293 | $5K | |
| 83655 | <1% | 367 | $5K | |
| 92587 | <1% | 324 | $5K | |
| 99173 | <1% | 1,146 | $4K | |
| 90674 | <1% | 759 | $4K | |
| 3008F | <1% | 3,824 | $3K | |
| 82950 | <1% | 561 | $3K | |
| 90697 | <1% | 860 | $3K | |
| 90677 | <1% | 976 | $2K | |
| 99222 | Initial hospital care, per day, moderate complexity | <1% | 20 | $2K |
| 99401 | <1% | 92 | $2K | |
| 90688 | <1% | 281 | $2K | |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 86 | $2K |
| 99223 | Prolong inpt eval add15 m | <1% | 12 | $2K |
| 99204 | Doctor's office visit, new patient (more involved) | <1% | 14 | $1K |
| 99395 | Periodic comprehensive preventive medicine reevaluation, established patient, 18-39 years | <1% | 16 | $1K |
| 90680 | <1% | 1,729 | $1K | |
| 99442 | <1% | 55 | $1K | |
| 90756 | <1% | 71 | $1K | |
| 99462 | <1% | 46 | $1K | |
| 85018 | <1% | 366 | $948.49 | |
| 96160 | <1% | 38 | $856.75 | |
| 90698 | <1% | 430 | $853.50 | |
| 92558 | <1% | 146 | $731.68 | |
| 99443 | <1% | 15 | $599.91 | |
| 0502F | <1% | 19,638 | $520.00 | |
| 83037 | <1% | 57 | $505.23 | |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 48 | $489.97 |
| 99231 | Subsequent hospital care, per day, straightforward or low complexity | <1% | 13 | $399.76 |
| 90633 | <1% | 678 | $203.01 | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 36 | $183.70 |
| 90734 | <1% | 34 | $155.00 | |
| 90716 | <1% | 198 | $150.98 | |
| 90744 | <1% | 79 | $121.76 | |
| 90723 | <1% | 656 | $90.05 | |
| 90648 | <1% | 1,341 | $87.47 | |
| 90707 | <1% | 153 | $87.31 | |
| 91301 | <1% | 797 | $16.94 | |
| 0501F | 0% | 137 | $0.00 | |
| 90657 | 0% | 67 | $0.00 | |
| 90651 | 0% | 113 | $0.00 | |
| 3044F | 0% | 48 | $0.00 | |
| 90656 | 0% | 16 | $0.00 | |
| 90696 | 0% | 32 | $0.00 | |
| 90700 | 0% | 165 | $0.00 | |
| 90710 | 0% | 63 | $0.00 | |
| 90681 | 0% | 150 | $0.00 | |
| 99080 | 0% | 295 | $0.00 | |
| 90658 | 0% | 41 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialARNOLD, KELLY (MEDICAL DIRECTOR)